intuit post better expect quarter highlight
procedur acceler backdrop competit
fear intuit like spend drive barrier entri
ion sp china look like bigger driver
strong intuit report revenu mse
procedur growth mse repres bp
comp-adjust acceler adjust bp benefit sell
day strongest stack momentum quarter sever year
manag rais procedur guidanc
impli procedur growth high end guidanc model
note impli bp momentum deceler
could prove conserv system sale beat mse
gross placement mse larg driven sp delay discuss
commentari suggest capital-expenditure environ stabl
expect line ep beat mse
driven bp better expect gross margin bp
opex manag rais gm guidanc high end
prior narrow high end opex growth rang
increas ep estim vs prior pleas see
exhibit reconcili result vs mse exhibit guidanc updat
exhibit model chang
virtual first half concern revers beyond strong top bottom line
growth intern metric soundli address mani concern weigh
sentiment ytd procedur growth acceler bp vs expect
stabil acceler driven somewhat improv gener surgeri
capac sale product hernia colorect well improv
bariatr urolog trend driver continu improv
point upsid guidanc call bp deceler
high end system signific debat call
improv modestli q/q highest mark year vs
placement europ recov vs
ion sp updat sp placement slow us vs
endoscop issu temporarili slow commerci problem
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
resolv intraquart separ issu two quarter ago expect
return level growth model placement
acceler discuss definit timelin
sp intuit believ requir consist
increas need data robot model
indic like sp data requir may less
inform regulatori strategi given sp novel platform
singl port crc/gen surgeri driven advers event past ex
coviden sil port said need increas clinic data robot
clear ion place first commer system build clinic system
market expect commerci roll-out build us placement
ww placement pleas see thought sp vs ion
roll-out discuss morgan stanley healthcar confer
earli thought commentari focus larg spend capit
placement intuit shi spend aggress
see margin step materi third consecut year rather
expect flattish slightli declin margin compani seek invest
drive adopt put distanc competit comfort
bp margin compress vs previous model margin
expans commentari competit landscap high level
consist prior quarter cmr launch europ
expect acut near-term threat see intuit
focus invest window acceler instal base
leasing/usag base model geograph expans ion/sp model
gross system placement vs driven sp
us ion us china placement vs tepid
roll-out oper leas percentag increas model
vs continu assum trade-in peak
model y/i declin fewer trade-in drive higher
model y/i asp growth vs flat y/i growth prior model y/i
procedur growth vs prior account slower sp ion
china procedur pull system perspect could
sourc upsid next year adopt go pronounc
procedur pull driver pleas see exhibit model
framework reli heavili year growth termin valu rather
near-term ep remain construct intuit phase still drive
signific growth compani scratch surfac phase
build foundat phase detail phase orient
thesi see look iri year estim remain fundament
unchang dcf-deriv price target remain key assumpt
includ wacc termin growth oper margin
expans procedur momentum drive valu creation
expans procedur momentum drive valu creation
price target base discount cash
flow model assum wacc termin growth rate
long term oper margin dcf impli
multipl base case cash ep
bull case ep
bull case ep
gener surgeri ex us procedur acceler adopt gener surgeri
ex us geographi two larg under-penetr market pick
drive sustain procedur growth competit
appear less near-term manag execut materi buyback
drive earn growth higher earli adopt sp ion build
dcf base analysi support base ep
dcf base analysi support base ep
steadi procedur growth expand estim sale
compound-annual-growth-rate driven annual procedur
growth partial off-set util growth averag revenu headwind
mix increas invest pressur margin cost reduct
buyback augment earn growth sp launch ion
launch
bear case ep
bear case ep
procedur growth moder competit intensifi visibl toward
product offer launch time concern investor pressur growth
margin expect procedur growth drop mid-teen level recent
momentum dvh dvp hernia ex us growth hold
oper margin drop intuit invest heavili ahead
competit launch mix becom larger headwind anticip
trend procedur improv
leav us confid sustain
revenu growth intuit overal
procedur growth acceler
margin sustain low
improv trend procedur
placement allow margin
remain elev even invest increas
prepar competit
pipelin expand sp
system open natur orific singl
incis market ion system open
endolumin market primari focu
lung biopsi treatment
us hernia total procedur drive
pt procedur growth growth
ex us procedur drive pt
procedur growth growth
sp file commerci on-going
updat augment realiti imag
risk achiev price
hernia address market smaller
gynecolog urolog growth materi
competit medtron
million except ep
interest incom expens
amort purchas ip
higher end
exhibit intuit surgic chang revenu model
exhibit intuit surgic chang incom statement
sale
sale
sale
sale
sale
sale
exhibit intuit surgic chang metric
good sold
interest incom
dv procedur procedur million
invest
long-term debt net defer tax
treasuri
accumul comprehens
loss sale plant equip
net chang work capit
chg invest secur
net invest
chg short-term debt
chg long-term debt
chang equiti
net financ
effect exchang rate chang
begin period
end period
